Description:
Griffin holds the Rosenberg Chair in Quantum Sensing and leads Strathclyde work on chip-scale/MEMS optically pumped magnetometers, unshielded operation, and applications from magnetocardiography and magnetomyography to magnetic-anomaly detection and space quantum technologies. This vapour-phase approach reaches femto-to-picotesla sensitivities complementary to NV-center diamond ensemble quantum sensors (DEER, nano-NMR, T1 relaxometry) that operate near the pT/sqrt(Hz) regime.
Haueisen leads biomagnetic-source modelling and analysis and OPM-based magnetomyography/MEG, bridging bioelectromagnetism theory, instrumentation and clinical neuroscience (with the Biomagnetic Center Jena). The work complements NV-center diamond ensemble quantum sensing (DEER, NMR, T1 relaxometry) at pT/sqrt(Hz) sensitivity by pursuing the same field-sensing goals in a different physical platform.
Marquetand pioneers OPM magnetomyography (measuring muscle magnetic fields) and applies clinical OPM-MEG to epilepsy and neuromuscular disease. This vapour-phase approach reaches femto-to-picotesla sensitivities complementary to NV-center diamond ensemble quantum sensors (DEER, nano-NMR, T1 relaxometry) that operate near the pT/sqrt(Hz) regime.
Middelmann develops OPM-based magnetorelaxometry imaging of magnetic nanoparticles, vector OPMs and OPM magnetomyography/MEG at PTB. This vapour-phase approach reaches femto-to-picotesla sensitivities complementary to NV-center diamond ensemble quantum sensors (DEER, nano-NMR, T1 relaxometry) that operate near the pT/sqrt(Hz) regime.